Dr. Darshika Chhabra, MD

Dr. Chhabra practices at Advocate Christ Medical Center in Oak Lawn, Illinois, part of Advocate Health.

Dr. Chhabra's NPI, 1003015116, was assigned on July 18, 2007. Dr. Chhabra graduated from Topiwala National Medical College in 2002. Dr. Chhabra holds Illinois license 036-117304.

Dr. Chhabra's primary practice is Advocate Christ Medical Center, at 4440 W 95th Street, Oak Lawn, IL 60453 in Cook County. The practice phone is (708) 684-8000.

Dr. Chhabra's primary practice is Advocate Christ Medical Center in Oak Lawn, Illinois, part of Advocate Health. The medical group on file is Dreyer Medical Clinic (Advocate Medical Group). Dmand AI also links Dr. Chhabra to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chhabra practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Chhabra's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Chhabra is board certified in internal medicine by the American Board of Internal Medicine. Dr. Chhabra is licensed in Illinois.

Dmand AI lists chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Chhabra treats.

CMS data shows 461 Medicare services from Dr. Chhabra across 5 procedure codes in 2024, for 112 Medicare patients. Medicare paid $42,308 for them.

CMS counts 112 Medicare patients who saw Dr. Chhabra in 2024. The largest group is under 65, with 60 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 34% are also on Medicaid. Their average risk score is 6.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chhabra's median patient age at 67, with 51% women.

In 2024, Dr. Chhabra wrote 1,048 Medicare Part D claims for 84 patients. 92% of them were for generic drugs. CMS names the drug for 864 of them, across 26 drugs with 11 or more claims each, at $82,458 in total drug cost. In 2023, CMS named 369 claims across 15 drugs.

Dr. Chhabra accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Chhabra, published from 2009 to 2022. 2009 was the busiest year, with 2. The most frequent topics are Kidney Transplantation, Graft Survival and Immunosuppressive Agents. Dr. Chhabra's most frequent co-authors are Lorenzo G. Gallon, MD, Joseph R. Leventhal, MD and Anton Skaro, MD, PhD.

Dmand AI links Dr. Chhabra to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 34 general payments to Dr. Chhabra from 13 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 100% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $393.

Dr. Chhabra graduated from Topiwala National Medical College in 2002.

Dr. Chhabra is in network with 17 carriers, including Aetna, HCSC and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.